Almac Diagnostics Licenses GeneGo's MetaCore | GenomeWeb
NEW YORK (GenomeWeb News) - GeneGo said last week that Almac Diagnostics, a division of Almac Group, has licensed its MetaCore data-mining platform.
 
Almac Diagnostics will use MetaCore to help develop its microarray-based products diagnosing and treating cancer.
 
The company will also use the platform in its genomic services division.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.